A Phase 1 Trial of OPA-15406 Ointment in Healthy Adult Male Subjects
Status:
Completed
Trial end date:
2015-02-01
Target enrollment:
Participant gender:
Summary
To assess the safety (especially skin findings) and pharmacokinetics by applying 0.3%, 1%, or
3% formulation of 5g OPA-15406 ointment to a 1000 cm2 area as a single-dose and as a
multiple-dose twice daily for 2 weeks in Japanese healthy adult male subjects.